News article by the Centre for Genomic Pathogen Surveillance — 27 April 2020 Pathogen surveillance is a crucial part of early-stage and ongoing responses to COVID-19. The UK consortium on…
Our study in _Nature Microbiology_ indicates that the major driver of the carbapenem resistant _K. pneumoniae_ epidemic in Europe has been transmission of hospital-adapted clones through healthcare networks
Combining the strengths of the European Centre for Disease Prevention and Control, the Wellcome Sanger Institute and the Centre for Genomic Pathogen Surveillance will improve the monitoring and tracking of…
A WHO Technical Note has been published that will enable health authorities to make informed choices on the most appropriate molecular tests in order to achieve a clearer picture of…
CGPS to house the Global Health Research Unit to monitor antibiotic resistant bacteria around the globe. Read more at https://www.sanger.ac.uk/news/view/new-global-health-initiative-genomic-surveillance-antimicrobial-resistance-funded-nihr